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Application of targeted 2D planar chromatography 
in the control of ginkgolic acids in some herbal drugs 
and dietary supplements
Two-step targeted 2D planar chromatographic method (2D-
TLC) was used in the determination of ginkgolic acids in 
pharmaceuticals and dietary supplements. The choice of 
the extraction method and the separation technique was 
guided by the formulation type (capsule, tablet, tincture) 
with expected low amounts of ginkgolic acids in the ana-
lyzed herbal samples. Separation of ginkgolic acids C15:1 
and C17:1 on HPTLC RP18 WF254s was preceded by its sepa-
ration from the sample matrix on TLC Si60 F254s. Mobile 
phases consisted of acetonitrile/water/formic acid (80:20:1, 
V/V/V) and n-heptane/ethyl acetate/formic acid (20:30:1, 
V/V/V), resp. Identification of separated compounds was 
based on 2D-TLC co-chromatography with reference sub-
stances and off-line 2D-TLC x HPLC-DAD-ESI-MS analysis. 
Quantification of ginkgolic acids C15:1 and C17:1 was con-
ducted densitometrically. Among the analyzed products, 
the presence of ginkgolic acids was confirmed only in herbal 
drugs containing 60 % ethanolic tinctures of Ginkgo biloba 
leaves. The use of TLC in the quantification of ginkgolic 
acids C15:1 and C17:1 in ginkgo extracts was described for 
the first time.
Keywords: ginkgolic acids, herbal products, 2D planar chro-
matography, HPLC-DAD-ESI-MS, densitometry
Alkylphenols present in Ginkgo biloba L. (also known as ginkgolic acids) belong to a 
group of 2-hydroxy-6-alkylbenzoic acid derivatives. Their structures differ in the length of 
the alkyl chain, the number and the location of double bonds. The main ginkgolic acids, 
C13:0, C15:1 and C17:2, have been determined both in nutshells and leaves of Ginkgo biloba 
(1–7). The content of alkylphenols in ginkgo leaves can reach up to 100,000 µg g–1.
Ginkgolic acids are considered undesirable compounds of ginkgo leaves extract be-
cause of their proven cytotoxic, mutagenic, neurotoxic, hepatotoxic and nephrotoxic acti-
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presence of these compounds (16). However, studies conducted by Satyan et al. (16) pointed 
out that, as long as the carboxyl group is present in the structure of ginkgolic acid conju-
gates, these compounds have no allergenic properties and, on the contrary, exert anti- 
 -allergic activity. Moreover, studies conducted on rats had proven that some ginkgolic acid 
conjugates (namely, n-tridecyl-, n-pentadecyl-, n-heptadecyl-, n-pentadecenyl- and n-hep-
tadecenylsalicylates) were responsible for anxiolytic activities of ginkgo leaves extracts 
(16). Other studies highlighted ginkgolic acids as candidates for antitumour drugs because 
of their ability to induce apoptosis and inhibit cell cycle progression, protein SUMOylation 
and metastasis (17–19).
In order to reduce the side-effects of ginkgolic acids, it has been established that the 
concentration in pharmaceuticals should not exceed 5 µg g–1 (20, 21). Qualitative and quan-
titative analyses of ginkgolic acids in extracts and products are mostly conducted with the 
use of high-performance liquid chromatography (HPLC) that is considered more sensitive 
and accurate than thin-layer chromatography (TLC) (22–25). However, it has been shown 
that the development of TLC analysis allows the use of TLC interchangeably with HPLC 
both in qualitative and quantitative surveys (26, 27).
Chromatographic conditions enabling TLC separation and the identification of the 
main ingredients responsible for therapeutic properties (flavonoids and terpene lactones) 
of ginkgo extract were described in European Pharmacopoeia (28), but also in several pub-
lished articles (20, 21). Separation of ginkgolic acids with the use of TLC in herbal extracts 
has not been described so far.
The main obstacle in the determination of the composition of herbal extracts is the 
complex nature that hinders the separation and the determination of single components. 
Therefore, more and more sophisticated procedures, including multidimensional separa-
tion techniques, were employed (29, 30). Among them, targeted 2D planar chromatography 
(2D-TLC), focused on the separation of a single compound or a group of compounds, is the 
most selective (29). It enables the use of a wide range of adsorbents and also incorporates 
both concentrating and purification within a single separation of the analyzed sample (29). 
In this technique, a part of the plate containing the partly separated compound is cut off 
and the compound is transferred to the second stationary phase for subsequent analysis. 
The separation can be performed on one or different adsorbents (29–32). If the separation 
is carried out on different adsorbents, both bilayer plates (33) or graft TLC techniques (34) 
can be used. Unless the number of types of bilayer TLC plates available on the market is 
limited, graft TLC allows any types of adsorbents to be combined and thus appears to be 
the most useful (29–32, 35).
In the present study, qualitative and quantitative analyses of the main ginkgolic acids 
(C15:1 and C17:1) in four drugs and four dietary supplements were performed for the first 
time with the use of TLC. Targeted 2D planar chromatography, along with HPLC-DAD-E-




Analytical grade solvents were purchased from POCh, Poland (methanol, acetone, 
ethyl acetate, and ethanol 96 %), Merck, Germany (n-heptane, acetonitrile, tetrahydrofu-
ran, and formic acid). Deionized water was obtained using the Elix/Synergy system (Merck-
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-Millipore, USA). The standards of ginkgolic acid C15:1 and ginkgolic acid C17:1 were pur-
chased from Merck GmbH (Germany). Stock solutions (1 µg µL–1) of reference substances 
were prepared in methanol and stored at –20 oC.
Plant material and herbal products
The analyzed group of herbal products included liquid (60 % ethanolic tinctures of 
Ginkgo biloba leaves) and solid formulations, tablets and hard capsules, containing dry 
extracts of ginkgo leaves (Table I). Herbal drugs and dietary supplements were purchased 
from the pharmacies.
Table I. The analyzed herbal products
Symbol Drug form
Content of dry ginkgo extract 
(mg in a tablet or a capsule)
Status
D1 Hard capsule 80 Drug
D2 Tablet 114 Drug
S1 Tablet 60 Supplement
S2 Tablet 80 Supplement
S3 Hard capsule 80 Supplement
S4 Tablet 40 Supplement
T1 Tincture 60 % ethanolic extract of G. biloba leaves Drug
T2 Tincture 60 % ethanolic extract of G. biloba leaves Drug
Sample preparation
Five mL of the analyzed tinctures (T1, T2), equaling to 4.675 g or 4.525 g of Ginkgo 
leaves, resp. (Table I), were partitioned with 20 mL hexane in an Erlenmeyer flask on a 
magnetic stirrer at room temperature for 15 min. Fifteen mL of the hexane layer was col-
lected. The solvent was evaporated under reduced pressure at room temperature. The 
residue, corresponding to 3.506 g (T1) or 3.394 g (T2) of plant substance, was dissolved in 2 
mL of methanol and stored in a freezer at –20 oC.
Five tablets or opened hard capsules (Table I) were weighed and dispersed in 20 mL 
of water on a magnetic stirrer for 30 minutes. The suspension was partitioned with 50 mL 
of hexane. Forty-five mL of the hexane layer was collected and the solvent was evaporated 
under reduced pressure at room temperature. The dry residue was dissolved in 2 mL of 
methanol. The samples were stored in a freezer at –20 °C.
Optimization of chromatographic conditions
Preliminary separations were performed on silica TLC glass plates (TLC Si60 F254S, Mer-
ck, Germany) or silica gel modified with octadecylsilane groups (HPTLC RP18 WF254s, Mer-
ck). Mobile phases consisting of ethyl acetate, n-heptane, acetone, formic acid, acetic acid and 
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water were tested on TLC Si60 F254S plates (mobile phases NP1-NP13, Table II). Moreover, the 
samples were separated with the use of mobile phases consisting of acetonitrile, tetrahydro-
furan, water and formic acid on HPTLC RP18 WF254s plates (mobile phases RP1-RP11, Table 
II). The hexane-partitioned ginkgo tinctures T1 or T2 were applied next to ginkgolic acid 
C15:1 and ginkgolic acid C17:1 standard with the use of the Hamilton syringe (10 µL). Separa-
tions were conducted in a horizontal TLC chamber (Camag, Switzerland) at a distance of 40 
mm (Table II). Chromatograms were analyzed under UV light (λ = 254 and 366 nm) (Fig. 1).
Table II. Mobile phases tested in the study
Code
Composition of mobile phases tested on 
the TLC Si60 F254s plate
a Code
Composition of mobile phases tested 
on the HPTLC RP18 WF254s plate
NP1
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Targeted 2D-TLC separation
Nine samples were applied as 5-mm bands using Desaga HPTLC-AS 30 applicator 
(Desaga, Germany) [syringe volume – 10 µL, sample volume – 4 µL (tinctures) or 30 µL 
(solid forms), application speed – 0.33 µL s–1, carrier gas – nitrogen] 10 mm from the low 
edge and 7 mm from the side of TLC Si60 F254S glass plate cut to the proper size (10 × 5 cm) 
with the use of the TLC-cutter (OM Laboratory, Japan).
The separation in the first dimension was conducted on TLC Si60 F254S glass plate in 
the twin-through chamber (Camag) conditioned for 15 min with the mobile phase vapor. 
The separation was carried out with the use of n-heptane/ethyl acetate/formic acid (20:30:1, 







Fig. 1. Targeted 2D planar chromatography separation of ginkgolic acids C15:1 and C17:1 (T1, T2 – 
samples of tinctures; S1-4 – increasing amount of ginkgolic acid 15:1).
TLC conditions: I step: adsorbent – TLC Si60 F254s glass plate 100 mm ´ 50 mm, UV detection: l = 366 
nm, mobile phase – n-heptane/ethyl acetate/formic acid (20:30:1, V/V/V); distance: 40 mm.
II step: HPTLC RP18 WF254S glass plate 100 ´ 50 mm, UV detection: l = 254 nm, acetonitrile:water/
formic acid (80:20:1, V/V/V), distance: 40 mm.
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at room temperature for 10 min and analyzed under UV light (λ = 366 nm and 254 nm). The 
zone of ginkgolic acids (a complex visible as a blue band under UV light) was excised by 
cutting the plate with a TLC-cutter. The band of ginkgolic acids was transferred to the 
second glass plate, HPTLC RP18 WF254s (10 × 5 cm, prewashed with methanol and acti-
vated at 120 oC for 30 min), in a vertical chamber. Methanol was used as a mobile phase to 
transfer the band of alkylphenols at a distance of approximately 10 mm. During the trans-
ferring time, TLC and HPTLC plates were combined with the use of the device described 
by Łuczkiewicz et al. (31). TLC plate was then disconnected and HPTLC plate was dried. 
The separation was continued in the second dimension on HPTLC plate in the horizontal 
developing chamber (Camag) using acetonitrile/water/formic acid (80:20:1, V/V/V) as a mo-
bile phase at a distance of 40 mm (Fig. 1). The chromatogram was analyzed densitometri-
cally (λ = 320 nm).
Identification of ginkgolic acids
Preliminary identification of the separated compounds was based on co-chromato-
graphy with reference substances. Next, the zones referring to ginkgolic acids C15:1 and 
C17:1 were scraped off from the plate and extracted with methanol. Qualitative analysis 
was conducted in the modified HPLC-DAD-ESI-MS system described by Xian-guo et al. 
(24). The HPLC system (Shimadzu, Japan) consisted of chromatographic pumps (LC 20AD), 
injector (autosampler SIL 20ACXL), DAD detector (SPD M20A), degasser (DGU 20AS), col-
umn oven (CTO 20AC) and interface (CBM 20A). The system was controlled by Labsolu-
tions (Shimadzu) software. The isocratic separation was carried out on a Discovery C18 
(150 mm × 2.1 mm, 5 µm, Supelco, USA) column at 45 oC with the use of a mobile phase of 
acetonitrile:water/acetic acid (92:7:1, V/V/V; flow rate 0.5 mL min–1). The separated com-
pounds were applied directly to LC-ESI-MS detector (LC-MS 2020, Shimadzu). The spectra 
Fig. 2. Densitograms of analyzed samples and ginkgolic acid C15:1 and C17:1 standards separated by 
the use of targeted 2D planar chromatography (T1, T2 – samples of tinctures; S1-S3 – increasing 
amount of ginkgolic acid 15:1). For TLC conditions for step I and step II see Fig. 1.
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were acquired in the negative-ion mode: mass range measured: 300–600 m/z, block tem-
perature: 200 oC, desolvation line (DL) temperature: 250 oC, detector voltage: 1 kV, interface 
voltage: 4.5 kV (Fig. 2).
Quantitative analysis
Increasing amounts of standard (200, 500 and 1000 ng) and two samples in triplicate 
were separated on each plate. The chromatograms were analyzed densitometrically (CD 
60 apparatus controlled by ProQuant 1.03.300 software (Desaga) and every track was 
scanned in linear mode (slit height – 0.02 mm, slit width – 6 mm, wavelength – 320 nm, 
scanning mode – absorbance, the average peak area of four measurements in the spot was 
recorded).
Preliminary validation
It included the assessment of detection limit (LOD), quantification limit (LOQ), linear-
ity, instrument precision, repeatability of measurement, inter-day and intra-day precision 
and recovery (Table III). The limits of detection (LOD) and quantification (LOQ) were de-
termined by analysis of ginkgolic acids standards (50–2000 ng per spot) by using signal-
-to-noise ratio 3:1 and 10:1, resp. (Table III). The precision of the measurement was calcu-
Table III. Validation parameters for quantitation of ginkgolic acids in herbal products
Parametera Ginkgolic acid C15:1 Ginkgolic acid C17:1
Linearity (ng per point)b 90–1500 80–1400
LOD (ng per point)c 50 50
LOQ (ng per point)c 170 160
R2 d           0.996–0.999
Repeatability of measurement (RSD, %)e 0.7 1.3
Repeatability of sample application (RSD, %)f 1.7 2.1
Intra-day precision (RSD, %)g 





Recovery (%)i 98–105 97–108
a Parameters recorded densitometrically under UV light (λ = 320 nm).
b Analysis of increasing amounts of reference compounds applied in duplicates (4 increasing concentrations). 
c  Analysis of increasing amounts of reference compounds at levels corresponding to the S/N ratio of 3 and 10 (de-
termination of LOD and LOQ, resp.).
d Average R2 calculated for 3-point calibration curves on different plates.
e Repeated (n = 9) scanning of a single band of the reference compound.
f Repeated (n = 9) application of the same amount of the reference compound on a single TLC plate.
g Analyses of the same sample within one day (3 independent analyses in triplicate).
h Analyses of the same sample on 3 subsequent days (3 independent analyses in triplicate).
i Analyses of samples spiked with a known amount of ginkgolic acid (3 independent analyses in triplicate).
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lated basing on the repeated scanning of standards spots (n = 9) at 320 nm (Table III). The 
assigned range of method linearity showed that it enabled the quantification of ginkgolic 
acids C15:1 and C17:1 in the range of 90–1500 ng per point and 80–1400 ng per point, resp., 
with the correlation coefficient of R2 > 0.996 (Table III). Intra-day precision was studied by 
the analysis of the sample in triplicate on three TLC plates for one day; for inter-day preci-
sion, the same analyst repeated analyses on three consecutive days (Table III).
Recovery study based on the standards addition method was used in the assessment 
of the method accuracy. Ginkgolic acid 15:1 and 17:1 standards were added to the samples 
at two levels, 25 and 50 % of the analyzed content in the sample, and each was analyzed as 
described above (Table III). The tinctures (T1 and T2) were used for validation of the de-
veloped method.
RESULTS AND DISCUSSION
Optimization of experimental conditions
Tinctures and water-dispersed tablets or capsules were partitioned with hexane. The 
previously described selectivity of hexane towards alkylphenols (despite high levels of 
polyphenols in ginkgo extracts) (14) and its low boiling point which enabled rapid concen-
trating of samples at room temperature, made it a useful choice for preparing samples for 
analyses. Separation of the main ginkgolic acids C15:1 and C17:1 with the use of planar 
chromatography has not been described so far. In the present study, attempts to separate 
the compounds were carried out both under normal phase and reverse phase conditions. 
Glass plates covered with silica gel (TLC Si60 F254s) or silica gel modified with octadecyl-
silane groups (HPTLC RP18 WF254s) were used for this purpose.
Separations of ginkgolic acids on TLC glass plates covered with silica gel (TLC Si60 
F254s) were conducted under normal phase conditions with the use of solvent mixtures 
consisting of variable proportions of n-heptane, ethyl acetate, acetone and formic acid 
(Table II). It has been noted that the greater the concentration of ethyl acetate or acetone in 
the mobile phase, the worse the separation of analyzed compounds from interfering sub-
stances. For this reason, the addition of n-heptane was needed to slow down the migration 
of the ginkgolic acids zone. However, zones of the separated compounds were tailing dur-
ing the development which impeded their identification. It has been observed that the 
addition of formic acid improves the shape of the separated zones with ginkgolic acids. 
Separation of ginkgolic acids zone from the interfering compounds was achieved under 
normal phase conditions. The well-separated ginkgolic acids zone was visible (λ = 366 nm) 
near the front of the mobile phase on TLC Si60 F254s plate developed at a distance of 40 mm 
with the use of n-heptane/ethyl acetate/formic acid (20:30:1, V/V/V). Nonetheless, none of 
the thirteen mobile phases tested in the study has enabled the separation of ginkgolic acids 
C15:1 and C17:1 from one another.
Attempts of ginkgolic acids C15:1 and C17:1 separation were continued under the re-
verse phase conditions on HPTLC RP18 WF254s plates at a distance of 40 mm. Mobile phases 
consisting of variable amounts of acetonitrile, tetrahydrofuran, water and formic acid 
were tested (Table II). It was noted, that the addition of formic acid in mobile phase im-
proved the shape of ginkgolic acids zones. Ginkgolic acids’ zones migrated together in all 
of the used mobile phases containing tetrahydrofuran (phases RP7-RP11, Table II). In turn, 
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increasing the concentration of acetonitrile in the mobile phase enhanced the retention 
factor of ginkgolic acids zones and hindered the separation. Among the analyzed mobile 
phases containing acetonitrile (RP1 – RP6, Table II), the mobile phase consisting of aceto-
nitrile/water/formic acid (80:20:1, V/V/V, mobile phase RP6) was chosen for further studies. 
However, the separation of ginkgolic acids was impeded by the accompanied constituents 
that made the quantitative analysis impossible.
Fig. 3. UV spectra and ion chromatograms of the TLC-separated ginkgolic acids C15:1 and C17:1 re-
corded by HPLC-DAD-ESI-MS analysis: a) UV spectrum of ginkgolic acid C15:1, b) UV spectrum of 
ginkgolic acid C17:1, c) ion chromatogram at m/z 345 and m/z 373 of ginkgolic acid C15:1, d) ion chro-
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For this reason, based on the literature data and our own experiences (29, 30), targeted 
2D planar chromatography technique combining concentrating, purification, and separa-
tion of sample’s constituents was used in further studies. Maintaining orthogonal rules, 
separation of ginkgolic acids was conducted consecutively on TLC Si60 F254s and HPTLC 
RP18 WF254s glass plates with the use of the best mobile phases described above (Figs. 1 and 
2, Table II). Separation of ginkgolic acids from the accompanying less lipophilic constitu-
ents was obtained in the first dimension using n-heptane/ethyl acetate/formic acid (20:30:1, 
V/V/V) on TLC Si60 F254s plate. Basing on chromatogram analysis under UV light, the frag-
ment of TLC plate containing alkylphenols band was cut off. The final separation of gink-
golic acids was preceded by transferring of this band from TLC Si60 F254S glass plate on 
HPTLC RP18 WF254s glass plate with methanol. Ginkgolic acids C17:1 and C15:1 were sepa-
rated by the use of the mobile phase consisting of acetonitrile/water/formic acid (80:20:1, 
V/V/V) to an extent that allowed their qualitative and quantitative analysis (Figs. 1, 2).
Analytical parameters
The assigned range of method linearity showed that it enabled the quantification of 
ginkgolic acids C15:1 and C17:1 in the range of 90–1500 ng per point and 80–1400 ng per 
point, resp., with the correlation coefficient of R2 > 0.996 (Table III). However, the presence 
of accompanied compounds made the quantification of less than 170 ng per spot of C15:1 
and less than 160 ng per spot of C17:1 impossible (Table III).
Meanwhile, the accompanying substances have limited the application of greater vo-
lumes of analyzed samples due to the adsorbent overloading and tailing of constituent 
zones during the TLC chromatogram development. It was found out, that up to 30 µL of 
extract from tablets or capsules could be applied on the TLC plate with no influence on the 
separation of ginkgolic acids. This volume limitation enabled the quantification of no less 
than 10 µg g–1 of ginkgolic acid C15:1 or C17:1 in the analyzed products.
Analytical application
The identification of ginkgolic acids bands was based on 2D-TLC co-chromatography 
along with HPLC-ESI-MS analysis in the presence of reference substances (25). It was 
found out that ginkgolic acids C15:1 and C17:1 were dominant alkylphenols in the ana-
lyzed tinctures T1 and T2 of ginkgo leaves (Figs. 1–3). Ginkgolic acids were not detected in 
tablets or capsules.
The quantitative analysis was conducted densitometrically with the use of the develo-
ped targeted 2D planar chromatography method. The analyzed samples were applied on 
each plate next to increasing amounts of the reference substances in order to reduce the 
influence of variable chromatographic conditions (e.g., humidity, temperature, atmospheric 
pressure) on the separation of the compounds. The procedure of ginkgolic acids’ quanti-
fication had been preliminary validated (Table III). Due to the fact that the developed 2D-
TLC method combined the purification and the separation of the analyzed samples, the 
procedure of sample preparation was simplified and therefore shortened. As in any TLC, 
the solvent consumption analysis was significantly lower in comparison with HPLC as 
two samples were determined during a single separation.
Ginkgolic acids C15:1 and C17:1 were determined in the analyzed tinctures T1 and T2; 
these products contained similar quantities of ginkgolic acids, ranging 209 to 283 mg g–1. 
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Based on the quantitative data, the concentration of ginkgolic acid C15:1 and C17:1 in 60 % 
ethanolic extracts of ginkgo leaves was significantly greater than the acceptable level of 5 
µg g–1, specified in the European Pharmacopoeia for ginkgo dry extract (Table IV) (28). Our 
results are in accordance with Schwabe’s patent (14) and are pointing out that the concen-
tration of ginkgolic acids in commercial extracts may reach 320 µg g–1 (14).
CONCLUSIONS
The aim of this study was to quantitatively and qualitatively analyze the ginkgolic 
acids present in herbal products with the use of the planar chromatography technique. The 
developed targeted 2D planar chromatography combined concentration, purification, and 
separation of the main ginkgolic acids C15:1 and C17:1. This study has proven that planar 
chromatography is useful, not only for qualitative, but also for quantitative analysis of 
ginkgolic acids in mono- and multi-component herbal products.
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